Spanish adaptation and validation of the Brief Negative Symptoms Scale

被引:55
作者
Mane, A. [1 ,2 ,3 ]
Garcia-Rizo, C. [3 ,4 ]
Garcia-Portilla, M. P. [3 ,5 ]
Berge, D. [1 ,2 ]
Sugranyes, G. [6 ,7 ]
Garcia-Alvarez, L. [3 ]
Bernardo, M. [3 ,7 ]
Bobes, J. [3 ,5 ]
Fernandez-Egea, E. [3 ,8 ,9 ,10 ]
机构
[1] Inst Neuropsiquiatria & Adicc, Barcelona, Spain
[2] Fundacio IMIM, Barcelona, Spain
[3] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain
[4] Hosp Clin Barcelona, Inst Neurosci, Barcelona Clin, Schizophrenia Unit, Barcelona, Spain
[5] Univ Oviedo, Dept Psychiat, Oviedo, Spain
[6] Hosp Clin Barcelona, Inst Neurosci, Child & Adolescent Psyquiatr Unit, Barcelona, Spain
[7] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain
[8] Univ Cambridge, Dept Psychiat, Cambridge CB2 1TN, England
[9] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 1TN, England
[10] Cambridgeshire & Peterborough NHS Fdn Trust, Peterborough, Cambs, England
基金
英国医学研究理事会;
关键词
SCHIZOPHRENIA;
D O I
10.1016/j.comppsych.2014.05.024
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Negative symptoms prevalent in schizophrenia are associated with poor outcome. Developing new instruments to identify new treatments was highlighted at the NIMH-MATRICS Consensus Development Conference on Negative Symptoms. The new Brief Negative Symptoms scale (BNSS) demonstrated strong psychometric properties, but there is a need for validating it in non-English languages. A multi-center study was conducted to validate the Spanish version of the BNSS (BNSS-Sp) in 20 schizophrenia patients, following the original BNSS validation methodology. We found strong inter-rater, test-retest and internal consistency properties (for the total BNSS-Sp, intraclass correlation coefficient = 0.97, Pearson's correlation coefficient r = 0.95 (p < 0.001), Cronbach's alpha = 0.98). (C) 2014 Elsevier Inc. All tights reserved.
引用
收藏
页码:1726 / 1729
页数:4
相关论文
共 9 条
[1]  
Andreasen N.C., 1989, BR J PSYCHIAT S, P49
[2]   THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) FOR SCHIZOPHRENIA [J].
KAY, SR ;
FISZBEIN, A ;
OPLER, LA .
SCHIZOPHRENIA BULLETIN, 1987, 13 (02) :261-276
[3]   The NIMH-MATRICS consensus statement on negative symptoms [J].
Kirkpatrick, B ;
Fenton, WS ;
Carpenter, WT ;
Marder, SR .
SCHIZOPHRENIA BULLETIN, 2006, 32 (02) :214-219
[4]  
Kirkpatrick B, 2008, WORLD PSYCHIATRY, V7, P143
[5]   The Brief Negative Symptom Scale: Psychometric Properties [J].
Kirkpatrick, Brian ;
Strauss, Gregory P. ;
Linh Nguyen ;
Fischer, Bernard A. ;
Daniel, David G. ;
Cienfuegos, Angel ;
Marder, Stephen R. .
SCHIZOPHRENIA BULLETIN, 2011, 37 (02) :300-305
[6]   The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation [J].
Kring, Ann M. ;
Gur, Raquel E. ;
Blanchard, Jack J. ;
Horan, William P. ;
Reise, Steven P. .
AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (02) :165-172
[7]   Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: Analysis of CATIE data [J].
Rabinowitz, Jonathan ;
Levine, Stephen Z. ;
Garibaldi, George ;
Bugarski-Kirola, Dragana ;
Berardo, Carmen Galani ;
Kapur, Shitij .
SCHIZOPHRENIA RESEARCH, 2012, 137 (1-3) :147-150
[8]   Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale [J].
Strauss, Gregory P. ;
Keller, William R. ;
Buchanan, Robert W. ;
Gold, James M. ;
Fischer, Bernard A. ;
McMahon, Robert P. ;
Catalano, Lauren T. ;
Culbreth, Adam J. ;
Carpenter, William T. ;
Kirkpatrick, Brian .
SCHIZOPHRENIA RESEARCH, 2012, 142 (1-3) :88-92
[9]   A New Perspective on Anhedonia in Schizophrenia [J].
Strauss, Gregory P. ;
Gold, James M. .
AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (04) :364-373